Posted on January 29th, 2014. Posted by ICR Westwicke
2013 was an incredible year for the United States initial public offering (IPO) market — the best since 2000. Of the 222 companies that went public, a record 55 companies (or 24.7 percent) were from healthcare, which experienced more IPOs than any other sector. Will healthcare break the 55 IPOs record in 2014? Time will tell.
Unless you’ve been stranded on a distant planet, you’ve noticed that equity markets have been hitting new highs lately, and that’s been accompanied by an increasingly robust capital markets environment, even including initial public offerings (IPOs). In fact, the current public healthcare IPO backlog stands at 14, with many more companies already confidentially initiating plans to pursue going public over the remainder of the year.
As recently as six months ago when we would meet with CFOs and CEOs of private companies (or their venture investors), they would have long lists of reasons why their company would never go public. The reasons included cost of capital, the hassle of being a public company, legal requirements, and compliance costs. All of these are particular burdens for smaller companies. In addition, if executives or investors were looking for an exit, they calculated better valuations if they sold to a strategic acquirer or private equity firm. An IPO was truly an option of last resort. Today, when we meet with these same constituents, we see a dramatic shift in their attitude towards going public.
Changing Tides for Healthcare Companies
So what has changed? The overall equity markets are much stronger, IPOs are getting done and trading up in the aftermarket and sentiment from the buy-side has become much more favorable. Some of this positive change has to be credited to the federal JOBS Act—a series of measures that allows private companies to become public in ways that are less burdensome and less costly.
Analyst communications play a key role in a company’s success. Download our checklist, 5 Tips for Effective Analyst Communications, for tips to maintain effective analyst relationships.
Our Locations
Baltimore
2800 Quarry Lake Drive, Suite 380
Baltimore, MD 21209 | (443) 213-0500 Directions
Boston
245 First Street, Riverview II, 18th Floor
Cambridge, MA 02142 | (339) 970-2843 Directions
Connecticut
761 Main Avenue
Norwalk, CT 06851 | (800) 210-2491 Directions
New York
685 Third Avenue, 2nd Floor
New York, NY 10017 | (800) 210-2491 Directions
Beijing
Unit 805, Tower 1, Prosper Center
No.5 Guanghua Road Chao Yang District
Beijing 100020, PR CHINA | (800) 210-2491 Directions